Topic: Aranesp
LOS ANGELES (Reuters) - Medicare officials do not plan at this time to change payment terms for anemia drugs used in kidney patients who are undergoing dialysis.The agency, which is slated to issue a final decision on the matter in June, also ...
Summary Box: FDA panel says anemia drugs should remain available for kidney disease patientsVOTE OF CONFIDENCE: A Food and Drug Administration panel of medical experts voted overwhelmingly to allow anemia drugs from Amgen Inc. to remain approved for patients with kidney disease, ...
A panel of Food and Drug Administration advisers voted not to restrict the use of anemia drugs like Epogen and Aranesp in kidney disease patients, either before they start getting dialysis or when they get it (a $2.6 billion market. ) This ...
FDA weighs restrictions of Amgen anemia drugs linked to stroke in kidney disease patientsThe Food and Drug Administration is considering new restrictions on widely used anemia drugs that appear to double the risk of stroke in patients with early-stage kidney disease.The FDA ...
LOS ANGELES (Reuters) - The U.S. Centers for Medicare and Medicaid Services (CMS) said on Wednesday it is reviewing its coverage of anemia drugs used to treat patients with kidney disease.The drugs, Epogen and Aranesp made by Amgen Inc and Procit made ...
Biotechnology company Amgen Inc. said Monday its profit rose 1 percent in the fourth quarter, as the company reported mixed results for its anemia drugs, but said sales of its other drugs held steady. Sales of one of Amgen's anemia drugs, Aranesp, ...
Amgen reports mixed 4Q results for anemia drugs but says revenue from other drugs was stableBiotechnology company Amgen Inc. said Monday its profit rose 1 percent in the fourth quarter, as the company reported mixed results for its anemia drugs, but said ...
Amgen shares fall as FDA officials urge dosing studies for anemia drugs in kidney patientsShares of Amgen Inc. fell Thursday over concerns that the Food and Drug Administration's plan to re-examine the safety of anemia drugs could pressure sales of leading anemia ...
Amgen says US District Court upholds ruling that blocks Roche from selling Mircera until 2014Swiss drugmaker Roche will not be allowed to sell its anemia drug Mircera in the U.S. until July 2014 under terms of a settlement with Amgen Inc., the ...
A giant trial finds the company's Aranesp drug nearly doubles the risk of strokes in kidney disease patients.. Aranesp sales have already been plummeting amid various safety problems, including a drumbeat of data showing drugs like it may boost deaths or tumor ...
From Around the Web
Video Gallery
-
Angie's Aranesp Injection (Equivalent to ...
I was nervous making this video so some of the ...2009-03-13 -
Safety Advisory on Procrit, Aranesp & Epogen ...
FDA has issued a Public Health Advisory which summarizes several ...2008-03-20 -
Rad injects with Aranesp
injecting my medication for the first time.2006-10-27
